A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming into Clinical Practice

BACKGROUND As physicians have increased opioid prescribing, overdose deaths from pharmaceutical opioids have substantially increased in the United States. Naloxone hydrochloride (naloxone), an opioid antagonist, is the standard of care for treatment of opioid induced respiratory depression. Since 1996, community-based programs have offered overdose prevention education and distributed naloxone for bystander administration to people who use opioids, particularly heroin. There is growing interest in translating overdose education and naloxone distribution (OEND) into conventional medical settings for patients who are prescribed pharmaceutical opioids. For this review, we summarized and classified existing publications on overdose education and naloxone distribution to identify evidence of effectiveness and opportunities for translation into conventional medical settings. METHODS For this review, we searched English language PubMed for articles on naloxone based on primary data collection from humans, including feasibility studies, program evaluations, surveys, qualitative studies, and studies comparing the effectiveness of different routes of naloxone administration. We also included cost-effectiveness studies. RESULTS We identified 41 articles that represented 5 categories: evaluations of OEND programs, effects of OEND programs on experiences and attitudes of participants, willingness of medical providers to prescribe naloxone, comparisons of different routes of naloxone administration, and the cost-effectiveness of naloxone. CONCLUSIONS Existing research suggests that people who are at risk for overdose and other bystanders are willing and able to be trained to prevent overdoses and administer naloxone. Counseling patients about the risks of opioid overdose and prescribing naloxone is an emerging clinical practice that may reduce fatalities from overdose while enhancing the safe prescribing of opioids.

[1]  L. Paulozzi Drug-induced deaths - United States, 2003-2007. , 2011, MMWR supplements.

[2]  Leonard J. Paulozzi,et al.  Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008. , 2011, MMWR. Morbidity and mortality weekly report.

[3]  M. Stein,et al.  Overdoses among friends: drug users are willing to administer naloxone to others. , 2006, Journal of substance abuse treatment.

[4]  K. Seal,et al.  Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area , 2003, Journal of Urban Health.

[5]  Christopher Welsh,et al.  "The life they save may be mine": diffusion of overdose prevention information from a city sponsored programme. , 2009, The International journal on drug policy.

[6]  S. Wakeman,et al.  Preventing Death Among the Recently Incarcerated: An Argument for Naloxone Prescription Before Release , 2009, Journal of addictive diseases.

[7]  K. Seal,et al.  Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: A pilot intervention study , 2005, Journal of Urban Health.

[8]  T. M. Piper,et al.  Overdose prevention for injection drug users: Lessons learned from naloxone training and distribution programs in New York City , 2007, Harm reduction journal.

[9]  Susan Okie,et al.  A flood of opioids, a rising tide of deaths. , 2010, The New England journal of medicine.

[10]  J. Rich,et al.  Physicians’ Knowledge of and Willingness to Prescribe Naloxone to Reverse Accidental Opiate Overdose: Challenges and Opportunities , 2006, Journal of Urban Health.

[11]  J. Rich,et al.  Prevention of fatal opioid overdose. , 2012, JAMA.

[12]  T. Valente,et al.  Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA. , 2010, The International journal on drug policy.

[13]  R. Heimer,et al.  Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States. , 2008, Addiction.

[14]  S. Lenton,et al.  Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond. , 2015, Drug and alcohol review.

[15]  T. Bennett,et al.  The impact of take-home naloxone distribution and training on opiate overdose knowledge and response: An evaluation of the THN Project in Wales , 2011 .

[16]  K. Mills,et al.  Rates and correlates of mortality amongst heroin users: findings from the Australian Treatment Outcome Study (ATOS), 2001-2009. , 2011, Drug and alcohol dependence.

[17]  Sanju George,et al.  A Guide for Clinicians on “Take Home” Naloxone Prescribing , 2008 .

[18]  S. Stancliff,et al.  Providing Naloxone to Substance Users for Secondary Administration to Reduce Overdose Mortality in New York City , 2007, Public health reports.

[19]  T. S. Jones,et al.  Community-based opioid overdose prevention programs providing naloxone - United States, 2010. , 2012, MMWR. Morbidity and mortality weekly report.

[20]  L. Paulozzi,et al.  Mental illness and psychotropic drug use among prescription drug overdose deaths: a medical examiner chart review. , 2010, The Journal of clinical psychiatry.

[21]  J. Strang,et al.  Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study , 2003, BMJ : British Medical Journal.

[22]  A. Orkin,et al.  Development and Implementation of an Opioid Overdose Prevention and Response Program in Toronto, Ontario , 2013, Canadian Journal of Public Health.

[23]  C. Taylor,et al.  Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability. , 1999, Addiction.

[24]  J. Elmore,et al.  Release from prison--a high risk of death for former inmates. , 2007, The New England journal of medicine.

[25]  Alex H. Kral,et al.  Overdose Prevention and Naloxone Prescription for Opioid Users in San Francisco , 2010, Journal of Urban Health.

[26]  S. Sullivan,et al.  Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal in Russian cities , 2013, Journal of medical economics.

[27]  N. Dasgupta,et al.  Opioid Drug Overdoses: A Prescription for Harm and Potential for Prevention , 2010 .

[28]  H. Surratt,et al.  Effect of abuse-deterrent formulation of OxyContin. , 2012, The New England journal of medicine.

[29]  T. M. Piper,et al.  Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York City. , 2006, Addictive behaviors.

[30]  K. Khoshnood,et al.  Expanded access to naloxone: options for critical response to the epidemic of opioid overdose mortality. , 2009, American journal of public health.

[31]  A. Kelly,et al.  Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose , 2005, The Medical journal of Australia.

[32]  W. Hall,et al.  Heroin overdose: causes and consequences. , 2001, Addiction.

[33]  S. Burris,et al.  Stopping an Invisible Epidemic: Legal Issues in the Provision of Naloxone to Prevent Opioid Overdose , 2009 .

[34]  Christopher M. Jones,et al.  Vital signs: risk for overdose from methadone used for pain relief - United States, 1999-2010. , 2012, MMWR. Morbidity and mortality weekly report.

[35]  C. Semmler,et al.  Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. , 2008, Addiction.

[36]  A. Kelly,et al.  Intranasal naloxone for the treatment of suspected heroin overdose. , 2008, Addiction.

[37]  N. Loimer,et al.  Nasal administration of naloxone is as effective as the intravenous route in opiate addicts. , 1994, The International journal of the addictions.

[38]  A. McAuley,et al.  Responsible management and use of a personal take-home naloxone supply: A pilot project , 2009 .

[39]  W. Hall,et al.  The distribution of naloxone to heroin users. , 1997, Addiction.

[40]  R. Heimer,et al.  A qualitative study of overdose responses among Chicago IDUs , 2008, Harm reduction journal.

[41]  D. Jolley,et al.  Attitudes of Australian Heroin Users to Peer Distribution of Naloxone for Heroin Overdose: Perspectives on Intranasal Administration , 2008, Journal of Urban Health.

[42]  Al Ozonoff,et al.  Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis , 2013, BMJ.

[43]  J. Buxton,et al.  A quantitative and qualitative evaluation of the British Columbia Take Home Naloxone program. , 2014, CMAJ open.

[44]  Li Hui Chen,et al.  Drug poisoning deaths in the United States, 1980-2008. , 2011, NCHS data brief.

[45]  C. Matheson,et al.  Reducing drug related deaths: a pre-implementation assessment of knowledge,barriers and enablers for naloxone distribution through general practice , 2014, BMC Family Practice.

[46]  Matthew D. Saybolt,et al.  Intranasal naloxone delivery is an alternative to intravenous naloxone for opioid overdoses. , 2010, The American journal of emergency medicine.

[47]  R. Heimer,et al.  Epidemiologic trends and geographic patterns of fatal opioid intoxications in Connecticut, USA: 1997-2007. , 2011, Drug and alcohol dependence.

[48]  J. Ioannidis,et al.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. , 2009, Journal of clinical epidemiology.

[49]  J. Havens,et al.  Individual and network factors associated with non-fatal overdose among rural Appalachian drug users. , 2011, Drug and alcohol dependence.

[50]  Karin A Mack,et al.  Pharmaceutical overdose deaths, United States, 2010. , 2013, JAMA.

[51]  J. Strang,et al.  Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes , 2001, BMJ : British Medical Journal.

[52]  S. B. Leavitt Intranasal Naloxone for , 2010 .

[53]  R. Heimer,et al.  Barriers to Medical Provider Support for Prescription Naloxone As Overdose Antidote for Lay Responders , 2013, Substance use & misuse.

[54]  S. Galea,et al.  Identifying injection drug users at risk of nonfatal overdose. , 2007, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[55]  E. Mackenzie,et al.  Attitudes of emergency medical service providers toward naloxone distribution programs , 2005, Journal of Urban Health.

[56]  C. Baca,et al.  What Heroin Users Tell Us About Overdose , 2007, Journal of addictive diseases.

[57]  S. Galea,et al.  Characteristics of drug users who witness many overdoses: implications for overdose prevention. , 2012, Drug and alcohol dependence.

[58]  J. Glanz,et al.  National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. , 2013, Drug and alcohol dependence.

[59]  I. Buajordet,et al.  Adverse events after naloxone treatment of episodes of suspected acute opioid overdose , 2004, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

[60]  K. Sporer Acute Heroin Overdose , 1999, Annals of Internal Medicine.

[61]  W. Hall,et al.  Heroin overdose: Research and evidence-based intervention , 2003, Journal of Urban Health.

[62]  J. Strang,et al.  Emergency naloxone for heroin overdose , 2006, British medical journal.

[63]  Yongli Xi,et al.  Increasing deaths from opioid analgesics in the United States , 2006, Pharmacoepidemiology and drug safety.

[64]  C. Latkin,et al.  Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives. , 2009, The International journal on drug policy.

[65]  T. Green,et al.  Opioid overdose prevention and naloxone distribution in Rhode Island. , 2011, Medicine and health, Rhode Island.

[66]  J. Steiner,et al.  Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors , 2012, Addiction Science & Clinical Practice.

[67]  Nabarun Dasgupta,et al.  Project Lazarus: community-based overdose prevention in rural North Carolina. , 2011, Pain medicine.

[68]  D. Jolley,et al.  Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose. , 2009, Addiction.

[69]  Alex H. Kral,et al.  Characteristics of an Overdose Prevention, Response, and Naloxone Distribution Program in Pittsburgh and Allegheny County, Pennsylvania , 2011, Journal of Urban Health.

[70]  Al Ozonoff,et al.  Opioid overdose prevention with intranasal naloxone among people who take methadone. , 2013, Journal of substance abuse treatment.

[71]  Sean D. Sullivan,et al.  Cost-Effectiveness of Distributing Naloxone to Heroin Users for Lay Overdose Reversal , 2013, Annals of Internal Medicine.

[72]  J. Hahn,et al.  Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study. , 2012, American journal of epidemiology.

[73]  R. Hoffman,et al.  Testing positive for methadone and either a tricyclic antidepressant or a benzodiazepine is associated with an accidental overdose death: analysis of medical examiner data. , 2006, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[74]  S. Galea,et al.  Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City , 2003, Journal of Urban Health.

[75]  Sarz Maxwell,et al.  Prescribing Naloxone to Actively Injecting Heroin Users , 2006, Journal of addictive diseases.

[76]  Leonard J Paulozzi,et al.  Patterns of abuse among unintentional pharmaceutical overdose fatalities. , 2008, JAMA.

[77]  B. Psaty,et al.  Opioid Prescriptions for Chronic Pain and Overdose , 2010, Annals of Internal Medicine.

[78]  P. Friedmann,et al.  Revisiting Paulozzi et al.'s "Prescription drug monitoring programs and death rates from drug overdose". , 2011, Pain medicine.

[79]  S. Galea,et al.  Opiate users' knowledge about overdose prevention and naloxone in New York City: a focus group study , 2006, Harm reduction journal.

[80]  T. Wolfe,et al.  Efficacy of intranasal naloxone as a needleless alternative for treatment of opioid overdose in the prehospital setting. , 2005, The Journal of emergency medicine.

[81]  T. M. Piper,et al.  Evaluation of a Naloxone Distribution and Administration Program in New York City , 2008, Substance use & misuse.

[82]  S. McDonald,et al.  Cognitive impairment among methadone maintenance patients. , 2000, Addiction.

[83]  D. Wermeling Opioid Harm Reduction Strategies: Focus on Expanded Access to Intranasal Naloxone , 2010, Pharmacotherapy.

[84]  A. Håkansson,et al.  Utdelning av naloxon för att förebygga död i heroinöverdos. Studie av opiatberoende patienters attityder till att ingå i antidotprogram. , 2013 .

[85]  S. Burris,et al.  Changing Law from Barrier to Facilitator of Opioid Overdose Prevention , 2013, The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics.

[86]  P. Moyer,et al.  Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. , 2009, American journal of public health.

[87]  J. Rich,et al.  Preventing Opiate Overdose Deaths: Examining Objections to Take-Home Naloxone , 2010, Journal of health care for the poor and underserved.

[88]  M. Valenstein,et al.  Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths , 2012 .

[89]  N. Wright,et al.  Homeless drug users' awareness and risk perception of peer "Take Home Naloxone" use – a qualitative study , 2006, Substance abuse treatment, prevention, and policy.

[90]  D. Best,et al.  Can we prevent drug related deaths by training opioid users to recognise and manage overdoses? , 2009, Harm reduction journal.

[91]  K. Wagner,et al.  Injection Drug Users Trained by Overdose Prevention Programs: Responses to Witnessed Overdoses , 2013, Journal of Community Health.